An Epidemiologic Study on PD-L1 Expression Combined With Clinical Observation in the Chinese MIUBC Patients.

CompletedOBSERVATIONAL
Enrollment

248

Participants

Timeline

Start Date

May 18, 2020

Primary Completion Date

March 27, 2023

Study Completion Date

March 27, 2023

Conditions
Urinary Bladder Cancer
Trial Locations (17)

100034

Research Site, Beijing

100730

Research Site, Beijing

110001

Research Site, Shenyang

130021

Research Site, Changchun

200032

Research Site, Shanghai

200072

Research Site, Shanghai

250012

Research Site, Jinan

310014

Research Site, Hangzhou

361003

Research Site, Xiamen

410013

Research Site, Changsha

450052

Research Site, Zhengzhou

510060

Research Site, Guangzhou

510120

Research Site, Guangzhou

610041

Research Site, Chengdu

2100008

Research Site, Nanjing

Unknown

Research Site, Meizhou

CN-430030

Research Site, Wuhan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY